COPENHAGEN, Denmark, April 16, 2026 - Evaxion A/S (NASDAQ: EVAX) ('Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, held its Annual ...
Company to participate in Live Virtual Investor Closing Bell segment today, April 16th?at?4:00 PM ET- Register for the event here OCALA, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (N ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results